Latest updates for Glenmark Holding

Fresh curated links around Glenmark Holding are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Glenmark launches generic Olanzapine injection in US
  • Glenmark Shifts to High-Margin Proprietary Space with Historic European Launch of Winlevi Acne Cream
  • Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

thehindubusinessline.com /1 week ago

Glenmark launches generic Olanzapine injection in US

Read source
tradebrains.in /1 month ago

Glenmark Shifts to High-Margin Proprietary Space with Historic European Launch of Winlevi Acne Cream

Synopsis: Glenmark Pharmaceuticals has launched Winlevi® (clascoterone 10 mg/g cream) across key European markets for the treatment of acne vulgaris. The launch marks Glenmark’s fi...

Read source
tradebrains.in /3 weeks ago

Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?

Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs 19,000 crore AbbVie deal that could unl...

Read source
thehindubusinessline.com /1 week ago

Marksans Pharma acquires German OTC distributor ABCnow GmbH for €892,384

The acquisition gives Marksans direct front-end sales and distribution infrastructure in Germany, which will be used for marketing products manufactured across its India, UK, and U...

Read source
pharmexec.com /1 month ago

<![CDATA[GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc. ]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion]]>

Read source
thehindubusinessline.com /2 weeks ago

Merck launches GCC in Bengaluru

Merck’s Bengaluru GCC to bring together approximately 3,300 professionals

Read source
pharmexec.com /1 week ago

<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>

Read source
iharare.com /1 week ago

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN – Media Out...

Read source
wispolitics.com /14 hours ago

Dept. of Justice: Wisconsin DOJ announces $29.6 million settlement with Glenmark over alleged conspiracy to inflate pric...

MADISON, Wis. – The Wisconsin Department of Justice (DOJ) joined a coalition of 48 states and territories announcing a $29.6 million settlement with Glenmark to resolve allegations...

Read source
thehindubusinessline.com /2 days ago

Gland Pharma: What should you do?

Margin improvement from higher value-added products and expanding portfolio should support earnings growth

Read source
thehindubusinessline.com /1 month ago

GVRP, StepsBio set up CoE for formulations R&D in Bengaluru

GSRC is designed to tackle complex formulation challenges by combining advanced scientific infrastructure with specialised workflows for drug delivery systems, sterile injectables,...

Read source
thehindubusinessline.com /3 weeks ago

Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Read source
pharmexec.com /3 weeks ago

<![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>

Read source
thehindubusinessline.com /6 days ago

Garware Fulflex Completes Acquisition of 300,000-Square-Foot Fully Automated Medical Products Manufacturing Facility in...

Garware Fulflex Completes Acquisition of 300,000-Square-Foot Fully Automated Medical Products Manufacturing Facility in The United States

Read source
thehindubusinessline.com /1 week ago

Granules India gets First-To-File status for generic Lumryz tablets in US

This was Granules’ second Sole First-to-File ANDA, following its earlier approval for Amphetamine Extended-Release Tablets,

Read source
pharmexec.com /1 month ago

<![CDATA[Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Joh...

Read source
cafepharma.com /1 month ago

Blenrep

Blenrep Anonymous (not verified) Thu, 05/28/2026 - 11:40 field_thread_url https://cafepharma.com/boards/threads/blenrep.714532/ board na...

Read source
seekingalpha.com /1 week ago

Novartis: 'Hold' On Continued Generic Erosion And Need For H2 2026 Catalysts

Read source
pharmexec.com /3 weeks ago

<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>

Read source
cafepharma.com /3 weeks ago

Blenrep

Blenrep Anonymous (not verified) Thu, 06/18/2026 - 23:58 field_thread_url https://cafepharma.com/boards/threads/blenrep.714532/ board na...

Read source
genengnews.com /3 weeks ago

AbbVie to Acquire Apogee Therapeutics for $10.9B

Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is a long-acting treatment that, according to the company, holds “pipeline-in-a-product potential” beca...

Read source
cafepharma.com /1 month ago

Flemming’s replacement

Flemming’s replacement Anonymous (not verified) Wed, 06/03/2026 - 14:44 field_thread_url https://cafepharma.com/boards/threads/flemming%E2%80%99s-replaceme...

Read source
tradebrains.in /1 month ago

Shilpa Medicare Subsidiary Acquires 30.4% Stake Worth ₹63 Cr in Spanish Biotech Firm Gate2Brain

Synopsis: Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, will acquire a 30.4% stake in Spanish biotech company Gate2Brain for €7 million (around Rs. 63 crore). The p...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Glenmark Holding

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

iharare.com

Recent coverage from public sources
Public source

tradebrains.in

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source